<DOC>
	<DOCNO>NCT01577589</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics Ceftaroline 600 mg administer vary infusion volume .</brief_summary>
	<brief_title>A 2-part Study Assess Local Tolerability , Safety Pharmacokinetics Ceftaroline Healthy Subjects</brief_title>
	<detailed_description>A Phase I , Single-center , 2-part , Randomized , 2-way Crossover Study Assess Local Tolerability Safety ( Multiple-dose ) Assess Pharmacokinetics , Safety , Tolerability ( Single-dose ) Ceftaroline Healthy Subjects Ceftaroline Fosamil Diluted Various Infusion Volume</detailed_description>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Provision inform consent prior study specific requirement Women childbearing potential must negative pregnancy test , nonlactating , use highly effective form birth control 3 month prior enrollment , study , 3 month completion studyrelated proceed Male volunteer must willing use barrier contraception first day dose 3 month last dose IP . Have body mass index ( BMI ) 18 30 kg/m2 , weigh least 50 kg Healthy male and/or female volunteer age 18 75 year inclusive , vein back hand forearm suitable cannulation repeat venipuncture . Use investigational compound participation another clinical trial within 1 month prior first administration IP study History clinically significant disease disorder ( e.g. , neurological , haematological , psychiatric , gastrointestinal , hepatic , renal disease ) Positive serology result screen serum hepatitis B surface antigen , hepatitis C antibody ( HCV ) , human immunodeficiency virus ( HIV ) History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant abnormality physical examination , lab , 12lead ECG vital sign judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>cross-over study</keyword>
	<keyword>ceftaroline fosamil</keyword>
	<keyword>various infusion volume</keyword>
	<keyword>local tolerability</keyword>
	<keyword>Cmax</keyword>
	<keyword>tmax</keyword>
	<keyword>AUC</keyword>
</DOC>